ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AVCT Avacta Group Plc

45.00
-1.50 (-3.23%)
Last Updated: 10:02:23
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Avacta Group Plc LSE:AVCT London Ordinary Share GB00BYYW9G87 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.50 -3.23% 45.00 44.50 45.50 46.50 44.75 46.50 1,055,887 10:02:23
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 10.06M -39.19M -0.1382 -3.24 126.92M
Avacta Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AVCT. The last closing price for Avacta was 46.50p. Over the last year, Avacta shares have traded in a share price range of 43.25p to 166.50p.

Avacta currently has 283,614,110 shares in issue. The market capitalisation of Avacta is £126.92 million. Avacta has a price to earnings ratio (PE ratio) of -3.24.

Avacta Share Discussion Threads

Showing 79476 to 79496 of 79850 messages
Chat Pages: Latest  3182  3181  3180  3179  3178  3177  3176  3175  3174  3173  3172  3171  Older
DateSubjectAuthorDiscuss
07/3/2024
08:14
Field

Everyone wishes for better cancer treatments, which makes spinning yarn (if that happens) for personal gain, all the more abhorrent.

This is a direct rehash of an abandoned plan in the US with Tufts.

Relevant staff from the collaboration ended up at Avacta (now left). It was simply taken from the defunct Arisaph to the AIM to gloss up and resell to the market.

If people have the kitchen sink in it, then it would be very wise to know what ended the progress in the US.

After all it’s now facing US permissions with no guarantee.

So what caused it to be abandoned before where at least one founder was a billionaire.

No note I have seen, mentions previous failure to progress, which makes such notes with wild claims, flawed (intentionally or by incompetence). The FDA will have records of the previous paths.

This isn’t new, Arisaph were progressing things 10-12 years ago, but the company wound up in about 2017.

Not long after Arisaph staff appear at Avacta along with the abandoned therapies.

So Avacta are now pushing for US approval, where for unknown reasons it was abandoned.

Was it regulatory failure, safety, lack of efficacy, cash/backers certainly wasn’t a problem.


In the case of pump and dump, the above is irrelevant.
In the case of a long term hold for the future of a family, it’s crazy not to seek out the truth.

If anyone trusts AIM company CEOs, then 90% of the time it’s misplaced trust in a con artist. The riches spin is the most common and easiest trick in the book.

Retail fall for it, funds, traders and shorters, rely on retail falling for it. Without large numbers of retail investors it doesn’t work.

Companies can get it working with news after news containing riches type blurb.

ohwhatfun
07/3/2024
06:27
Blackvulture - the most obvious trader here. Disappears for day at a time. share price fall, up he pops. Mr Shallows way to go.
amanitaangelicus
06/3/2024
20:34
I see that this bulletin board is still infested with with little children no sorry grownups which are not invested and haven't got a clue what Avacta is all about. Sad really.
blackvulture
06/3/2024
18:51
Hopefully....another 20 years in you yet fieldhouse.

Avacta will probably be doing cohort 21 of Phase 2a by then.

1347
06/3/2024
16:30
You.ve been trapped Fieldhouse. Darn.
amanitaangelicus
06/3/2024
13:40
Hopefully....another 20 years in you yet fieldhouse.
filthypoor
06/3/2024
10:14
PWYou are right. My mistake.
countbasie1
06/3/2024
08:45
The RTO minerals company chasing cancer therapeutics.

A great example of the AIM, spin and huge salaries end on one idea, so the existing AIM entity via another route fleeces the market again.

No doubt those behind it have seen how retail how reacted to one, so chase the same idea to attract hoping for the same result, buying something for peanuts then turn it into a £50m-£100m company, where nothing has actually changed.

It can be tough entering the AIM, far easier to RTO

EG some spin their world leading LFTs as worth billions, then buy into diagnostics as a big future, BUT, forget that, the new spin is keeping ‘em interested. 100’s of 1000’s bagged for a good free more years, job done boys forget all that junk we hyped up before.

And then one day in the future, reality kicks in, and the team management live happily ever after, having banked millions.

40’s next, the bounce hasn’t happened so 10’s of millions of shares bought low 50’s, in retail hands no one sell to.

ohwhatfun
06/3/2024
08:28
countbasie1 - The news may have been released last night but it certainly was not an RNS.
pwhite73
06/3/2024
08:15
PWThat RNS was released last night 3/5 UK time.Then it reappeared today.
countbasie1
06/3/2024
07:46
Note the date of 05/03/24 on both the globenewswire (above) and yahoo weblink (below). AVCT are passing it off as an RNS as of today 06/03/24.



How many presentations at the AACR have they made of this worthless witches potion.

pwhite73
06/3/2024
07:37
'With a balanced business and capital allocation model: a high-value oncology pipeline supported by a revenue generating, fast-growing diagnostics business, Avacta seeks to create long-term shareholder value alongside patient benefit' ...from the rns.Keep pumping Time Lord Smith. The gall on him.
amanitaangelicus
05/3/2024
23:04
As a non-shareholder, glad I did not waste my time, and the time of my broker, on 'taking up' the REX offer.
melody9999
05/3/2024
18:29
RNS 05/03/24 - "This financing has brought several new high-quality institutions onto the share register including a large European healthcare specialist fund"

If all that's been raised between SEVERAL new high-quality institutions and a large European healthcare specialist fund is £25 million between them they can't be that high quality.

Furthermore its only the REX Retail Offer is subject to the GM on 18/03/2024. The main placing has already been done so there should have already been TR1s for the institutions and large European Healthcare Fund if any had invested 3% or over.

pwhite73
05/3/2024
13:24
My charity holding gone pear-shaped here..Will try to double up when it hits 45p.. hopefully soon.
baldrick1
05/3/2024
08:33
Raj ...u sound like Whitey in disguise. Weird.
amanitaangelicus
05/3/2024
08:24
P White said that there are no new institutional investors or a Healthcare fund involved with us now. He said these companies , now mentioned twice on two separate RNS's, are just holding accounts. I don't know what to believe could AVCT become be really misleading us or do you think PWhite knows what he's talking about?
rajraj b
05/3/2024
07:56
Yes can’t argue with that as a vote of confidence. Now that’s all out of the way, time to take a position and tuck a few away.
bbd2
05/3/2024
07:51
This stock is losing so much money each month it's crazy they have raised 31 million wow . It will last about a year we're is the money for production if they ever get their . Wow total Scam
aimscam1
05/3/2024
07:48
good news

"we have limited the allocation under this REX Retail offer to existing shareholders only in order to minimise further dilution at this price.

stockhunters
04/3/2024
20:40
If it's an RTO it will be for an unlisted company. Why the hell would a minerals company take over a private pharma anyway. Stay well clear I'd say.
1347
Chat Pages: Latest  3182  3181  3180  3179  3178  3177  3176  3175  3174  3173  3172  3171  Older

Your Recent History

Delayed Upgrade Clock